Edouard De dreuzy
Company: Advesya France
Job title: Head of R&D
Seminars:
Development of a First in Class CAR T-Cell Investigational Product for the Treatment of r/r AML 10:00 am
Tackling on-target off-tumour toxicity in AML by targeting a unique, tumour associated antigen not expressed in healthy hematopoietic cells Designing a third generation CAR-T encompassing a highly specific scFv Developing a CAR-T investigational drug product demonstrating robust pre-clinical data in AML modelsRead more
day: Conference Day 1 - AM